VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
- PMID: 9690512
- DOI: 10.1038/sj.onc.1201928
VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development
Abstract
Upregulation of keratinocyte-derived VEGF-A expression has recently been established in non-neoplastic processes of skin such as wound healing, blistering diseases and psoriasis, as well as in skin neoplasia. To further characterize the effects of VEGF-A in skin in vivo, we have developed transgenic mice expressing the mouse VEGF120 under the control of a 2.4 kb 5' fragment of keratin K6 gene regulatory sequences that confers transgene inducibility upon hyperproliferative stimuli. As expected from the inducible nature of the transgene, two of the three founder mice obtained (V27 and V208), showed no apparent phenotype. However, one founder (V2), mosaic for transgene integration, developed scattered red spots throughout the skin at birth. The transgenic offspring derived from this founder developed a striking phenotype characterized by swelling and erythema, resulting in early postnatal lethality. Histological examination of the skin of these transgenics demonstrated highly increased vascularization and edema leading to disruption of skin architecture. Expression of the transgene was silent in adult animals of lines derived from founders V27 and V208. Phorbol ester-induced hyperplasia resulted in transgene induction and increased cutaneous vascularization in adult transgenic mice of these lines. Skin carcinogenesis experiments performed on hemizygous crosses of V208 mice with activated H-ras-carrying transgenic mice (TG.AC) resulted in accelerated papilloma development and increased tumor burden. Previous results from our laboratory showed that VEGF upregulation is a major angiogenic stimulus in mouse epidermal carcinogenesis. By overexpressing VEGF in the skin of transgenic mice we now move a step further toward showing that VEGF-mediated angiogenesis is a rate-limiting step in the genesis of premalignant lesions, such as mouse skin papilloma. Our transgenic mice constitute an interesting model system for in vivo study of the cutaneous angiogenic process and its relevance in tumorigenesis and other skin diseases.
Similar articles
-
Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.Cancer Res. 1996 Dec 1;56(23):5391-6. Cancer Res. 1996. PMID: 8968091
-
Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice.Biochem Biophys Res Commun. 1998 Jun 29;247(3):644-53. doi: 10.1006/bbrc.1998.8787. Biochem Biophys Res Commun. 1998. PMID: 9647747
-
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.Cancer Res. 2002 Jun 15;62(12):3402-7. Cancer Res. 2002. PMID: 12067982
-
Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Verh K Acad Geneeskd Belg. 2005. PMID: 16334858 Review.
-
Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.Med Sci Monit. 2000 Sep-Oct;6(5):1047-52. Med Sci Monit. 2000. PMID: 11208453 Review.
Cited by
-
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.J Clin Invest. 2003 Jan;111(1):43-50. doi: 10.1172/JCI16116. J Clin Invest. 2003. PMID: 12511587 Free PMC article.
-
Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism.EMBO J. 2001 Jun 1;20(11):2631-40. doi: 10.1093/emboj/20.11.2631. EMBO J. 2001. PMID: 11387198 Free PMC article.
-
Effects of nickel on cyclin expression, cell cycle progression and cell proliferation in human pulmonary cells.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1720-9. doi: 10.1158/1055-9965.EPI-09-0115. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505905 Free PMC article.
-
Role of VEGF in organogenesis.Organogenesis. 2008 Oct;4(4):247-56. doi: 10.4161/org.4.4.7415. Organogenesis. 2008. PMID: 19337405 Free PMC article.
-
Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.J Clin Invest. 2017 Feb 1;127(2):457-471. doi: 10.1172/JCI85145. Epub 2016 Dec 19. J Clin Invest. 2017. PMID: 27991863 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous